Ticker | Company name | Industry | Market Cap in Bln |
Dividend Yield | Dividend Frequency | Stock price | Currency | Stock Exchange |
---|---|---|---|---|---|---|---|---|
NVS | Novartis AG | Healthcare | 217.08 | 3.18 % | Annual | 95.63 | USD | New York Stock Exchange & Nasdaq Stock Market |
Company's Past Performance











The 5 years average P/E ratio is the average of each year’s P/E ratios. P/E ratio in any year is limited to 30 in order to reduce the effect of the extreme values on the average P/E.
Company Profile
Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment supplies generic pharmaceuticals. The Corporate Activities segment includes other items of income and expense which are not attributable to specific segments such as certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations, and sponsorships. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.